Treatment of Healthcare Company Provider Agreements Is Key in Chapter 11 Bankruptcy Sales
By Cameron Fine, Associate, & Rachel Nanes and Rachel Ehrlich Albanese, Partners, DLA Piper
Many healthcare companies, both for-profit and nonprofit, are facing increasing financial distress, causing many of them to seek relief under Chapter 11 of the U.S. Bankruptcy Code to restructure their financial obligations, sell substantially all of their assets, or implement an orderly plan of...
We hope you enjoyed your free content!
To continue, please become a TMA member.
Access the Journal of Corporate Renewal and other content in the Learning Link.
Become part of a global organization of turnaround and restructuring professionals with 54 Chapters and more than 400 events each year.
Build your personal brand and professional network with opportunities to connect, speak, lead, and win awards.
Rachel Ehrlich Albanese is a partner and vice chair of the U.S. Restructuring Group of the global law firm DLA Piper. She represents debtors, creditors, equity holders, purchasers of distressed assets, and other parties in a wide range of restructuring matters, including Chapter 11 cases, out-of-court workouts, and cross-border insolvency proceedings, as well as cases under title III of PROMESA. Albanese is co-chair of the NAWL Bankruptcy & Restructuring Affinity Group and an active member of TMA, ABI, and IWIRC, among others.
Rachel Nanes is a partner with DLA Piper in Miami. She focuses her practice in the area of corporate restructuring and has extensive experience in healthcare restructurings. Nanes represents debtors, secured creditors, committees of unsecured creditors, purchasers, and other interested parties in corporate restructurings, bankruptcy litigation, and other bankruptcy-related matters.
Cameron Fine is an associate with DLA Piper in Phoenix. He represents clients from a wide range of industries, including the healthcare, life sciences, medical device, and pharmaceutical sectors, in complex commercial litigation and regulatory matters in state and federal courts, as well as domestic and international arbitration. Fine has counseled healthcare-related clients through numerous legal issues, including trade secret misappropriation, fraud, product liability, False Claims Act, regulatory investigations, and litigation due diligence, among other issues.
